Axel Ullrich
For their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer
Affilié au moment de l'attribution du prix
Max Planck Institute of Biochemistry
Société Max-Planck pour le développement des sciences
Martinsried, Allemagne